Kiyotaka Kawashima

Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue

Erika M. Wolff, Yoshitomo Chihara, Fei Pan et al. · Cancer Research · 2010 · 182 citations · Full text

Medicine, Genetics, Oncology +16

Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non‐muscle invasive bladder cancer

Makito Miyake, Kokichi Sugano, Hitomi Sugino et al. · Cancer Science · 2009 · 89 citations · Full text

Medicine, Oncology, Urology +17

siRNA‐mediated Knockdown of the Heme Synthesis and Degradation Pathways: Modulation of Treatment Effect of 5‐Aminolevulinic Acid‐based Photodynamic Therapy in Urothelial Cancer Cell Lines

Makito Miyake, Masazumi Ishii, Kiyotaka Kawashima et al. · Photochemistry and Photobiology · 2009 · 78 citations

Medicine, Oncology, Pharmacology +16

Curative Surgery for Local Pelvic Recurrence of Rectal Cancer

Norio Saito, Keiji Koda, Nobuhiro Takiguchi et al. · Digestive Surgery · 2003 · 77 citations · Full text

Medicine, Oncology, Surgery +14

1-tert-Butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a Selective Tyrosine Kinase Inhibitor of Fibroblast Growth Factor Receptor-3 (FGFR3), Inhibits Cell Proliferation of Bladder Cancer Carrying the FGFR3 Gene Mutation along with Up-Regulation of p27/Kip1 and G1/G0 Arrest

Makito Miyake, Masazumi Ishii, Naoki Koyama et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 66 citations

Medicine, Oncology, Pharmacology +16